Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice

Journal of Nutrition

Volumn 133, Issue 2, 2003, Pages 516-521

  Zhou, Jin Rong ^a   Yu, Lunyin ^a   Zhong, Ying ^a   Blackburn, George L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Prostate cancer; Soy phytochemicals; Synergy; Tea

Indexed keywords

ANDROGEN; ANDROSTANOLONE; BLACK TEA EXTRACT; CAFFEINE; CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; FLAVONOL DERIVATIVE; GALLIC ACID; GREEN TEA EXTRACT; KAEMPFEROL; MYRICETIN; QUERCETIN; TESTOSTERONE; THEAFLAVIN; THEAFLAVIN 3,3' DIGALLATE;

ANDROGEN METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BEVERAGE; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CLINICAL RESEARCH; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG POTENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PROSTATE TUMOR; SOYBEAN; STATISTICAL SIGNIFICANCE; TEA; THEA NIGRA; TUMOR REGRESSION;

ANIMALIA; CAMELLIA SINENSIS; GLYCINE MAX;

EID: 0037317091     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.2.516     Document Type: Article

References (38)

1. Landis, S. H., Murray, T., Bolden, S. & Wingo, P.A. (1999) Cancer statistics. CA Cancer J. Clin. 49: 8-31.
2. Dhom, G. (1983) Epidemiological aspects of latent and clinically manifest carcinoma of the prostate. J. Cancer Res. Clin. Oncol. 106: 210-218.
3. Yatani, R., Kusano, I., Shiraishi, T., Hayashi, T. & Stemmermann, G. N. (1989) Latent prostatic carcinoma: pathological and epidemiological aspects. Jpn. J. Clin. Oncol. 19: 319-326.
4. Muir, C. S., Nectoux, J. & Staszewski, J. (1991) The epidemiology of prostate cancer. Geographic distribution and time-trends. Acta Oncol. 30: 133-140.
5. Parkin, D. M., Pisani, P. & Ferlay, J. (1999) Global cancer statistics. CA Cancer J. Clin. 49: 33-64.
6. Mandel, J. S. & Schuman, L. M. (1980) Epidemiology of cancer of the prostate. Rev. Cancer Epidemiol. 1: 1-65.
7. Boyle, P., Kevi, R., Lucchuni, F. & La Vecchia, C. (1993) Trends in diet-related cancers in Japan: a conundrum? Lancet 342: 752.
8. Morton, M. S., Griffiths, K. & Blacklock, N. (1996) The preventive role of diet in prostatic disease. Br. J. Urol. 77: 481-493.
9. Stellman, S. D. & Wang, Q. S. (1994) Cancer mortality in Chinese migrants to New York City. Comparison with Chinese in Tianjin and with United States-born whites. Cancer 73: 1270-1275.
10. Cook, L. S., Goldoft, M., Schwartz, S. M. & Weiss, N. S. (1999) Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J. Urol. 161: 152-155.
11. Whittemore, A. S., Kolonel, L. N., Wu, A. H., John, E. M., Gallagher, R. P., Howe, G. R., Burch, J. D., Hankin, J., Dreon, D. M. & West, D. W. (1995) Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J. Natl. Cancer Inst. 87: 652-661.
12. Dhom, G. (1991) Epidemiology of hormone-dependent tumors. In: Endocrine Dependent Tumors (Voigt, K.-D. & Knabbe, C., eds.), pp. 1-42. Raven Press, New York, NY.
13. Miller, G. J. (1988) Diagnosis of stage A prostatic cancer in the People's Republic of China. In: A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer (Coffey, D. S., Resnick, M. I., Dorr, F. A. & Karr, J. P., eds.), pp. 17-24. Plenum, New York, NY.
14. Klein, R. D. & Fischer, S. M. (2002) Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells. Carcinogenesis 23: 217-221.
15. Griffiths, K., Akaza, H., Eaton, C. L., El Etreby, M., Habib, H., Le, C., Partin, A. W., Coffee, D. S., Sciarra, F., Steiner, C. & Tenniswood, M. P. (1993) Regulation of prostatic growth. In: The 2nd International Consultation of Benign Prostatic Hyperplasia (BPH) (Cockett, A., Khoury, S., Aso, Y., Chatelain, C., Denis, L., Griffiths, D. K. & Murphy, G. P., eds.), pp. 49-75. SCI, Paris, France.
16. Lyn-Cook, B. D., Rogers, T., Yan, Y., Blann, E. B., Kadlubar, F. F. & Hammons, G. J. (1999) Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr. Cancer 35: 80-86.
17. Chemoprevention Working Group. (1999) Prevention of cancer in the next millennium: report of the Chemoprevention Working Group to the American Association for Cancer Research. Cancer Res. 59: 4743-4758.
18. Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S. & Mukhtar, H. (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. U.S.A. 98: 10350-10355.
19. Sato, N., Gleave, M. E., Bruchovsky, N., Rennie, P. S., Beraldi, E. & Sullivan, L. D. (1997) A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res. 57: 1584-1589.
20. Zhou, J.-R., Yu, L., Zhong, Y., Nassr, R. L., Franke, A. A., Gaston, S. M. & Blackburn, G. L. (2002) Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate. 53: 143-153.
21. Reeves, P. G., Hielsen, F. H. & Fahey, J. G. (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123: 1939-1951.
22. Zhou, J.-R., Mukherjee, P., Gugger, E. T., Tanaka, T., Blackburn, G. L. & Clinton, S. K. (1998) The inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res. 58: 5231-5238.
23. Zhou, J.-R., Gugger, E. T., Tanaka, T., Guo, Y., Blackburn, G. L. & Clinton, S. K. (1999) Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr. 129: 1628-1635.
24. Steel, R.G.D. & Torrie, J. H. (1980) Principles and Procedures of Statistics: A Biometrical Approach, 2nd ed. McGraw-Hill, New York, NY.
25. Yokoyama, Y., Dhanabal, M., Griffioen, A. W., Sukhatme, V. P. & Ramakrishnan, S. (2000) Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res. 60: 2190-2196.
26. Chou, T. C. & Talalay, P. (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22: 27-55.
27. Nam, S., Smith, D. M. & Dou, Q. P. (2001) Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276: 13322-13330.
28. Tijburg, L. B., Mattern, T., Folts, J. D., Weisgerber, U. M. & Katan, M. B. (1997) Tea flavonoids and cardiovascular disease: a review. Crit. Rev. Food Sci. Nutr. 37: 771-785.
29. Naik, H. R., Lehr, J. E. & Pienta, K. J. (1994) An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Res. 14: 2617-2619.
30. Peterson, G. & Barnes, S. (1993) Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22: 335-345.
31. Pollard, M. & Luckert, P. H. (1997) Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr. Cancer 28: 41-45.
32. Onozawa, M., Kawamori, T., Baba, M., Fukuda, K., Toda, T., Sato, H., Ohtani, M., Akaza, H., Sugimura, T. & Wakabayashi, K. (1999) Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats. Jpn. J. Cancer Res. 90: 393-398.
33. Aronson, W. J., Tymchuk, C. N., Elashoff, R. M., McBride, W. H., McLean, C., Wang, H. & Heber, D. (1999) Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. Nutr. Cancer 35: 130-136.
34. Folkman, J. (1989) What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82: 4-6.
35. Holash, J., Wiegand, S. J. & Yancopoulos, G. D. (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356-5362.
36. Paschka, A. G., Butler, R. & Young, C.Y.-F. (1998) Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 130: 1-7.
37. Liao, S., Umekita, Y., Guo, J., Kokontis, J. M. & Hiipakka, R. A. (1995) Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 96: 239-243.
38. Liao, S. & Hiipakka, R. A. (1995) Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun. 214: 833-838.